Reuters logo
2 months ago
BRIEF-Paradigm Biopharmaceuticals seeks trading halt
June 14, 2017 / 11:49 PM / 2 months ago

BRIEF-Paradigm Biopharmaceuticals seeks trading halt

June 15 (Reuters) - Paradigm Biopharmaceuticals Ltd

* Seeks trading halt pending review status of its current clinical trial in allergic rhinitis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below